Literature DB >> 13987629

Biochemistry of uric acid and its relation to gout.

J E SEEGMILLER, L LASTER, R R HOWELL.   

Abstract

Entities:  

Keywords:  URIC ACID

Mesh：

Substances：

Year:  1963        PMID： 13987629     DOI： 10.1056/NEJM196303282681306

Source DB:  PubMed          Journal:  N Engl J Med        ISSN： 0028-4793            Impact factor:   91.245


× No keyword cloud information.
  12 in total

Review 1.  Heberden oration 1979: human aberrations of purine metabolism and their significance for rheumatology.

Authors:  J E Seegmiller
Journal:  Ann Rheum Dis       Date:  1980-04       Impact factor: 19.103

2.  Contributions of Lesch-Nyhan syndrome to the understanding of purine metabolism.

Authors:  J E Seegmiller
Journal:  J Inherit Metab Dis       Date:  1989       Impact factor: 4.982

3.  Fractional excretion of uric acid in infancy and childhood. Index of tubular maturation.

Authors:  J H Passwell; M Modan; M Brish; S Orda; H Boichis
Journal:  Arch Dis Child       Date:  1974-11       Impact factor: 3.791

Review 4.  The study of human intermediary purine metabolism and its regulation.

Authors:  J E Seegmiller
Journal:  Proc R Soc Med       Date:  1966-04

5.  Hyperuricaemia: some biochemical aspects.

Authors:  R W Watts
Journal:  Proc R Soc Med       Date:  1969-08

6.  Urates and kinin formation in synovial fluid.

Authors:  V Eisen
Journal:  Proc R Soc Med       Date:  1966-04

7.  Current concepts of hyperuricemia and gout.

Authors:  J R Klinenberg
Journal:  Calif Med       Date:  1969-03

8.  In vivo effects of cellulose sulphate on plasma kininogen, complement and inflammation.

Authors:  V Eisen; C Loveday
Journal:  Br J Pharmacol       Date:  1971-07       Impact factor: 8.739

9.  Solubility of uric acid and monosodium urate.

Authors:  W R Wilcox; A Khalaf; A Weinberger; I Kippen; J R Klinenberg
Journal:  Med Biol Eng       Date:  1972-07

10.  Metastatic testicular cancer presenting with liver and kidney dysfunction treated with modified BEP chemotherapy combined with continuous hemodiafiltration and rasburicase.

Authors:  Mai Kimakura; Toyofumi Abe; Akira Nagahara; Kazutoshi Fujita; Hiroshi Kiuchi; Motohide Uemura; Norio Nonomura
Journal:  Anticancer Drugs       Date:  2016-04       Impact factor: 2.248
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.